Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	9,004	14,654	7,107	5,779	14,852	14,829
Short-Term Investments	57,684	43,254	74,363	56,018	29,513	19,744
Cash & Short-Term Investments	66,688	57,908	81,470	61,797	44,365	34,573
Cash Growth	-29.53%	-28.92%	31.84%	39.29%	28.32%	34.32%
Accounts Receivable	95,137	90,420	80,298	72,485	66,764	49,641
Other Receivables	3,003	2,967	2,908	1,451	5,051	4,815
Receivables	98,140	93,387	83,206	73,936	71,815	54,456
Inventory	75,600	71,085	63,552	48,670	50,884	45,412
Prepaid Expenses	2,005	1,883	1,947	1,452	1,138	1,141
Other Current Assets	27,465	25,849	17,874	18,398	13,654	12,667
Total Current Assets	269,898	250,112	248,049	204,253	181,856	148,249
Property, Plant & Equipment	102,784	97,761	76,886	66,462	62,169	57,111
Long-Term Investments	11,419	15,202	5,255	5,362	7,986	8,333
Goodwill	11,975	11,810	4,253	4,245	4,418	4,568
Other Intangible Assets	95,597	96,803	36,951	30,849	27,246	35,648
Long-Term Accounts Receivable	-	-	-	-	54	118
Long-Term Deferred Tax Assets	24,197	18,508	10,774	7,196	8,204	10,630
Other Long-Term Assets	3,667	2,793	5,350	3,487	894	834
Total Assets	519,537	492,989	387,518	321,854	292,827	265,491
Accounts Payable	37,457	20,053	21,547	17,857	15,971	12,696
Accrued Expenses	34,672	43,864	40,494	38,716	36,083	31,809
Short-Term Debt	38,381	38,045	12,723	7,390	27,082	23,145
Current Portion of Long-Term Debt	3,800	-	-	3,800	-	-
Current Portion of Leases	1,367	857	1,307	1,004	1,017	864
Current Income Taxes Payable	10,521	3,028	2,342	2,144	1,615	1,389
Current Unearned Revenue	1,834	1,983	1,435	1,981	2,576	2,033
Other Current Liabilities	14,559	22,562	16,191	12,953	9,671	11,455
Total Current Liabilities	142,591	130,392	96,039	85,845	94,015	83,391
Long-Term Debt	-	3,800	3,800	-	3,800	3,800
Long-Term Leases	5,096	4,064	2,190	1,278	1,946	2,499
Long-Term Unearned Revenue	1,152	1,162	1,193	1,555	1,597	1,531
Long-Term Deferred Tax Liabilities	14,450	14,108	909	833	60	338
Other Long-Term Liabilities	2,493	2,297	2,837	1,352	882	870
Total Liabilities	165,782	155,823	106,968	90,863	102,300	92,429
Common Stock	835	834	834	833	832	832
Additional Paid-In Capital	11,272	11,133	10,765	9,688	9,280	8,887
Retained Earnings	329,971	315,793	265,910	216,479	176,467	157,349
Treasury Stock	-2,041	-2,264	-991	-1,269	-1,601	-1,967
Comprehensive Income & Other	10,022	7,892	4,032	5,260	5,549	7,961
Total Common Equity	350,059	333,388	280,550	230,991	190,527	173,062
Minority Interest	3,696	3,778	-	-	-	-
Shareholders' Equity	353,755	337,166	280,550	230,991	190,527	173,062
Total Liabilities & Equity	519,537	492,989	387,518	321,854	292,827	265,491
Total Debt	48,644	46,766	20,020	13,472	33,845	30,308
Net Cash (Debt)	18,044	11,142	61,450	48,325	10,520	4,265
Net Cash Growth	-71.78%	-81.87%	27.16%	359.36%	146.66%	17.23%
Net Cash Per Share	21.64	13.36	73.72	58.09	12.65	5.13
Filing Date Shares Outstanding	832.37	832	832.64	830.78	829.79	828.63
Total Common Shares Outstanding	832.37	832	832.64	830.78	829.79	828.63
Working Capital	127,307	119,720	152,010	118,408	87,841	64,858
Book Value Per Share	420.56	400.71	336.94	278.04	229.61	208.85
Tangible Book Value	242,487	224,775	239,346	195,897	158,863	132,846
Tangible Book Value Per Share	291.32	270.16	287.45	235.80	191.45	160.32
Land	-	4,156	4,224	4,234	4,154	4,147
Buildings	-	28,335	27,992	26,519	24,663	23,634
Machinery	-	125,303	117,082	107,205	95,100	85,470
Construction In Progress	-	24,837	14,462	9,956	13,305	9,778

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q